| scholarly article | Q13442814 |
| P50 | author | Wilfried Renner | Q89575974 |
| P2093 | author name string | Bernhard Paulweber | |
| Thomas C Wascher | |||
| Gerald Wolf | |||
| Hellmut Samonigg | |||
| Peter Krippl | |||
| Uwe Langsenlehner | |||
| Josef Haas | |||
| Babak Yazdani-Biuki | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| breast cancer | Q128581 | ||
| P304 | page(s) | 468-471 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. | |
| P478 | volume | 106 |
| Q45092133 | A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer |
| Q36289803 | A functional variant in the 3'-UTR of VEGF predicts the 90-day outcome of ischemic stroke in Chinese patients |
| Q34568722 | A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants |
| Q45828775 | Advances of VEGR gene polymorphism and its clinical values in lung cancer |
| Q40429804 | Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever |
| Q89534299 | Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study |
| Q37315498 | Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study |
| Q37437235 | Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma. |
| Q37304321 | Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival. |
| Q82621190 | Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer |
| Q60956827 | Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer |
| Q34990498 | Association between the Functional Polymorphism of Vascular Endothelial Growth Factor Gene and Breast Cancer: A Meta-Analysis |
| Q35709085 | Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome |
| Q54264675 | Association between vascular endothelial growth factor +936 C/T gene polymorphism and age-related macular degeneration. |
| Q37348331 | Association between vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 18 case-control studies |
| Q57212098 | Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients |
| Q36638595 | Association of -2549 insertion/deletion polymorphism of vascular endothelial growth factor with breast cancer in North Indian patients. |
| Q54282835 | Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans. |
| Q46350810 | Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians. |
| Q48032239 | Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population |
| Q84337369 | Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma |
| Q40420700 | Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome |
| Q82040903 | Association of Vascular Endothelial Growth Factor Gene Polymorphisms With Susceptibility to Epithelial Ovarian Cancer |
| Q51567138 | Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction. |
| Q44122884 | Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population |
| Q37035051 | Association of vascular endothelial growth factor (VEGF) +405 g>c polymorphism with endometriosis in an Iranian population |
| Q90221020 | Association of vascular endothelial growth factor (VEGF) Gene polymorphisms and expression with the risk of endometriosis: a case-control study |
| Q37121685 | Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. |
| Q36854622 | Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer |
| Q37321890 | Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children. |
| Q57099477 | Associations between vascular endothelial growth factor gene polymorphisms and susceptibility to acute mountain sickness |
| Q34469737 | C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma |
| Q37180102 | Circulating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosis |
| Q53335025 | Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors. |
| Q81446293 | Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk |
| Q45220466 | Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility |
| Q54196655 | Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer. |
| Q37041198 | Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer |
| Q59136710 | Gene Polymorphism in Indonesian Subjects with Diabetic Polyneuropathy |
| Q41691362 | Genetic alterations of IDH1 and Vegf in brain tumors. |
| Q37090696 | Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk |
| Q64279723 | Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy |
| Q45900950 | Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran. |
| Q45065767 | Genetic variants of the sulfotransferase 1A1 and breast cancer risk |
| Q35912389 | Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study |
| Q33828717 | Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. |
| Q37310665 | Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis |
| Q36225882 | Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS |
| Q89359942 | Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population |
| Q35354678 | Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels |
| Q38307997 | Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity. |
| Q54470228 | Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer. |
| Q40721771 | Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk |
| Q43179296 | Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype |
| Q34894525 | Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans. |
| Q54545150 | Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. |
| Q34692175 | MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland. |
| Q55073231 | Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile. |
| Q54562952 | No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population. |
| Q35189242 | Oesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A. |
| Q42837601 | Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer. |
| Q54180020 | Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. |
| Q38358816 | Pharmacogenetics and breast cancer management: current status and perspectives |
| Q37725978 | Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab |
| Q36982859 | Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab |
| Q37326196 | Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer |
| Q43807701 | Polymorphisms in the 5′- and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics |
| Q35012794 | Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort |
| Q84646505 | Polymorphisms of VEGF, GSTM1 and GSTT1 genes in multiple myeloma risk |
| Q37521976 | Prevalence of +405G>C,-1154G>A Vascular Endothelial Growth Factor Polymorphism in Breast Cancer |
| Q38308001 | Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer |
| Q37187766 | Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer |
| Q33684757 | Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans |
| Q34996947 | Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients |
| Q34466706 | Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in China |
| Q51021068 | Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. |
| Q34341453 | Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients |
| Q35934127 | Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies |
| Q37428195 | Targeting angiogenesis in bladder cancer |
| Q54735606 | The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer. |
| Q41676310 | The Association Between VEGF +936C/T and -634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects |
| Q44627494 | The Common 677C>T Gene Polymorphism of Methylenetetrahydrofolate Reductase Gene is not Associated with Breast Cancer Risk |
| Q55001626 | The Importance of VEGF-KDR Signaling Pathway Genes should Not Be Ignored When the Risk of Developing Multiple Sclerosis is Taken into Consideration. |
| Q58602194 | The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer |
| Q82427987 | The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer |
| Q54583401 | The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. |
| Q37362585 | The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors |
| Q26851522 | The role of vascular endothelial growth factor a polymorphisms in breast cancer |
| Q39378690 | The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women |
| Q43832117 | The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population. |
| Q55461490 | Three single nucleotide polymorphisms of the vascular endothelial growth factor (VEGF) gene and glioma risk in a Chinese population. |
| Q55194696 | VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia. |
| Q45234431 | VEGF -460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma |
| Q34908859 | VEGF 936C > T Polymorphism and Association of BI-RADS Score in Women with Suspected Breast Cancer |
| Q36287686 | VEGF Gene Polymorphisms are Associated with Risk of Tetralogy of Fallot |
| Q36541140 | VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese |
| Q43110034 | VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population. |
| Q36746698 | VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib |
| Q84534882 | VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration |
| Q35448592 | VEGF polymorphisms and severity of atherosclerosis. |
| Q50883768 | VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival. |
| Q39063895 | Vascular endothelial growth factor (-460 C/T, +405 G/C, and +936 C/T) polymorphisms and endometriosis risk in Tunisian population |
| Q54386406 | Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. |
| Q46290881 | Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer |
| Q37666428 | Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case-control studies |
| Q36230748 | Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis |
| Q85059698 | Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study |
| Q54544986 | Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. |
| Q83200227 | Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India) |
| Q80479304 | Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients |
| Q37229446 | Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis. |
| Q37702734 | Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies |
| Q34938869 | Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis |
| Q61853685 | Vascular endothelial growth factor gene polymorphisms in ovarian cancer |
| Q36691776 | Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy |
| Q37565250 | Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility |
| Q35179707 | Vascular endothelial growth factor polymorphisms as effect modifiers of oral squamous cell carcinoma risk: A systematic review and meta-analysis |
| Q46714484 | WITHDRAWN: Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma |
Search more.